Pharmacy Times

JUNE 9, 2025

Tichy, PharmD, MBA, vice chair of pharmacy formulary for Mayo Clinic, explained. Dalton shared her surprise about how variability in manufacturing affects the patient experience, given that some products created using the patient’s cells may not always be usable or up to FDA standards.

Compounding Pharmacies 56

Compounding Pharmacies FDA Hospitals Immunization 56

Pharmacy Times

JULY 9, 2025

SHOW MORE FDA approves a new dosing schedule for donanemab, enhancing safety and efficacy in treating early symptomatic Alzheimer disease. This advancement provides healthcare professionals with improved confidence in managing Alzheimer's disease with donanemab.

Labelling 65

Labelling FDA Compounding Pharmacies Independent Pharmacies 65

Pharmacy Times

JUNE 26, 2025

In an interview with Pharmacy Times , Shaji Kumar, MD, consultant and research chair of the Division of Hematology in the Department of Internal Medicine at Mayo Clinic, discussed emerging data from the phase 2 RedirecTT-1 study (NCT04586426).

Compounding Pharmacies 65

Compounding Pharmacies Vaccines Immunization Mayo Clinic 65

Pharmacy Times

JULY 14, 2025

SHOW MORE FDA fast-tracks TRE-515 for advanced prostate cancer, combining it with radiation therapy to enhance treatment outcomes and patient care. The FDA has granted fast track designation to TRE-515 (Trethera Corporation), a novel drug, in combination with radiation therapy for the treatment of prostate cancer.

FDA 73

FDA Compounding Pharmacies Compounding Immunization 73

Pharmacy Times

JUNE 24, 2025

The FDA approved an autoinjector of belimumab (Benlysta; GSK) for the subcutaneous injection in children aged 5 years and older with active lupus nephritis (LN) who are receiving standard therapy. Despite advancements, LN remains a poor prognostic indicator in lupus, necessitating effective management strategies.

FDA 106

FDA Compounding Pharmacies Vaccines Immunization 106

Drug Topics

JUNE 24, 2025

The FDA approved belimumab (Benlysta), a 200 mg/mL autoinjection, for subcutaneous injection in patients 5 years of age and older with active lupus nephritis who are receiving standard therapy. FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis. Mayo Clinic. REFERENCES 1. News release.

FDA 509

FDA Immunization Vaccines Mayo Clinic 509

Pharmacy Times

JUNE 19, 2025

Standard-of-care treatment for patients with ALK fusions is alectinib (Alecensa; Genentech), a TKI that was approved by the FDA in 2024 for adjuvant treatment following tumor resection in patients with ALK-positive NSCLC. They are more common in younger patients and are often associated with a minimal smoking history.

Chemotherapy 73

Chemotherapy Compounding Pharmacies Hospitals Immunization 73

Pharmacy Times

JUNE 15, 2025

Following, HR+, HER2- early breast cancer is a common subtype where the cancer cells have estrogen and progesterone receptors but do not have excessive amounts of the HER2 protein, according to Mayo Clinic. Mayo Clinic. Clinicaltrials.gov: NCT05306340. Updated April 15, 2025. Accessed June 13, 2025. News release.

Mayo Clinic 106

Mayo Clinic Compounding Pharmacies Immunization Specialty Pharmacies 106

Drug Topics

JULY 16, 2025

Mayo Clinic. McKesson Series: Using Technology to Simplify Vaccination Programs December 22nd 2020 Podcast Our latest podcast episode discusses how pharmacies can tap technology to boost vaccination programs for COVID-19 vaccines and others. Self-reported resilience during the COVID-19 pandemic. JAMA Netw Open.

Specialty Pharmacies 316

Specialty Pharmacies Independent Pharmacies Compounding Vaccines 316

Pharmacy Times

JUNE 9, 2025

Mayo Clinic. Akkooi A, Mandala M, Kicinski M, Primary analysis of the EORTC-2139-MG/Columbus-AD trial: A randomized trial of adjuvant encorafenib and binimetinib versus placebo in high-risk stage II melanoma with a BRAF-V600E/K mutation. J Clin Oncol. 43, 2025 (suppl 17; abstr LBA9500). doi:10.1200/JCO.2025.43.17_suppl.LBA9500.

Compounding Pharmacies 82

Compounding Pharmacies Immunization Mayo Clinic Specialty Pharmacies 82

Pharmacy Times

JULY 18, 2025

Mayo Clinic. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. JAMA Netw Open. 2025;8(7):e2520011. doi:10.1001/jamanetworkopen.2025.20011 2025.20011 2. Long-term obesity and biological aging in young adults. EuerkAlert!

Compounding Pharmacies 73

Compounding Pharmacies Compounding Immunization Mayo Clinic 73

Pharmacy Times

JULY 14, 2025

The ADVANTAGE AF trial supported the FDA approval, showing 99.7% The FDA approved a label extension for the Farapulse Pulsed Field Ablation (PFA) system (Boston Scientific) to now include approval for the system in the treatment of drug-refractory, symptomatic persistent atrial fibrillation (AF).

Labelling 65

Labelling FDA Compounding Pharmacies Hospitals 65

The Checkup by Singlecare

SEPTEMBER 22, 2023

This year, there are new vaccines to help at-risk populations ward off severe sickness, including that caused by RSV. Here’s what you need to know about the new FDA-approved RSV vaccine. Is there a vaccine for RSV? Not all vaccines work via the same science. Is there an RSV vaccine for children? What is RSV?

Vaccines 105

Vaccines Immunization Insurance FDA 105

The Checkup by Singlecare

OCTOBER 10, 2023

Cephalexin and probiotics or oral live vaccines This one makes perfect sense. Oral live vaccines contain weakened bacteria, such as typhoid and cholera. These bacteria stimulate our immunity, but if given concurrently with an antibiotic, the bacteria from the vaccine could be eradicated before they have done their job.

Mayo Clinic 52

Mayo Clinic Vaccines Labelling Medical Records 52

SingleCare

JANUARY 2, 2020

associate director of Clinical Pharmacy at the University of Southern California School of Pharmacy in Los Angeles says they also administer immunizations recommended by the Centers for Disease Control and Prevention (CDC) including shingles , Tdap (tetanus, diphtheria and pertussis), HPV and pneumonia. Make medication adherence a priority.

Mayo Clinic 52

Mayo Clinic Vaccines Immunization Pharmaceutical Companies 52

The Checkup by Singlecare

OCTOBER 6, 2023

The interaction is severe enough that prescribing information for many NSAIDs warns against the concomitant use of corticosteroids in a Food and Drug Administration (FDA) issued Medication Guide. Still, they are independently associated with many significant side effects, much so that the FDA has issued guidance regarding their use.

Vaccines 52

Vaccines Mayo Clinic FDA Immunization 52

The Checkup by Singlecare

SEPTEMBER 27, 2023

Nitrofurantoin can interact with certain antacids, gout medications, anesthetics, and travel vaccines. This includes some antacids, gout medications, anesthetics, and travel vaccines, as well as methotrexate and fluconazole. However, sulfinpyrazone has been discontinued by the Food and Drug Administration (FDA).

Vaccines 52

Vaccines Mayo Clinic Compounding Communication 52

The Checkup by Singlecare

NOVEMBER 13, 2023

To help decrease the risk of shingles, Shingrix vaccine is FDA-approved for adults 50 and older. It is a two-vaccine series and significantly decreases the risk of a shingles outbreak. Antiviral medications such as Acyclovir ( zovirax ) and famciclovir are often prescribed.

Mayo Clinic 52

Mayo Clinic Vaccines Chemotherapy Communication 52

pharmaphorum

AUGUST 27, 2020

Already under fire for what some view as a premature authorisation of convalescent plasma for COVID-19, the FDA is now being accused of a blunder that could render current supplies unusable. Now, tragically, there is zero credibility for the upcoming @US_FDA review of #SARSCoV2 vaccines in the months ahead. .

FDA 105

FDA Mayo Clinic Labelling Communication 105